![Jude Onyia](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jude Onyia
Directeur Technique/Scientifique/R&D chez
NEUROCRINE BIOSCIENCES, INC.
Fortune : 4 M $ au 31/05/2026
Profil
Jude Onyia currently works at Voyager Therapeutics, Inc., as Director from 2023 and Neurocrine Biosciences, Inc., as Chief Scientific Officer from 2021.
Dr. Onyia also formerly worked at Eli Lilly & Co., as Vice President-Biotechnology Discovery Research from 2014 to 2021 and Capsida Biotherapeutics, Inc., as Chief Scientific Officer in 2021.
Dr. Onyia received his doctorate degree from State University of New York at Downstate Medical Center, undergraduate degree from Suny College of Environmental Science & Forestry, and doctorate degree from SUNY Upstate Medical University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 05/06/2026 | 23 405 ( 0,02 % ) | 4 M $ | 31/05/2026 | |
| 31/03/2026 | 2 910 ( 0 % ) | 11 262 $ | 31/05/2026 |
Postes actifs de Jude Onyia
| Sociétés | Poste | Début |
|---|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Directeur Technique/Scientifique/R&D | 30/11/2021 |
| VOYAGER THERAPEUTICS, INC. | Directeur/Membre du Conseil | 21/02/2023 |
Anciens postes connus de Jude Onyia
| Sociétés | Poste | Fin |
|---|---|---|
Capsida Biotherapeutics, Inc.
 Capsida Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in the development of gene therapies for life threatening genetic disorders | Directeur Technique/Scientifique/R&D | 01/11/2021 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/06/2021 |
Formation de Jude Onyia
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
78
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Neurocrine Biosciences, Inc.
 Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
SUNY College of Environmental Science
 SUNY College of Environmental Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SUNY Upstate Medical University
 SUNY Upstate Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
State University of New York at Downstate Medical Center
 State University of New York at Downstate Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Voyager Therapeutics, Inc.
 Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
Capsida Biotherapeutics, Inc.
Capsida Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in the development of gene therapies for life threatening genetic disorders | Health Technology |
